Christopher Mcguigan

Cognitive reserve in multiple sclerosis: The role of depression and fatigue.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 12, 2025

Characterisation of Platelet Releasate Proteome in Relapsing-Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics.

Journal: Proteomics. Clinical applications

Published: January 20, 2025

Corrigendum to: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10 G>T at the intron 9/exon 10 of the MAPT gene.

Journal: Neurobiology of aging

Published: September 24, 2024

A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies.

Journal: Journal of neuroimmunology

Published: September 21, 2024

Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 03, 2024

Autoimmune central nervous system disorders: Antibody testing and its clinical utility.

Journal: Clinical biochemistry

Published: December 22, 2023

Systematic review of cognitive reserve in multiple sclerosis: Accounting for physical disability, fatigue, depression, and anxiety.

Journal: Multiple sclerosis and related disorders

Published: June 21, 2023

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: March 17, 2023

Neuropsychology intervention for managing invisible symptoms of MS (NIMIS-MS) group: A pilot effectiveness and acceptability study.

Journal: Multiple sclerosis and related disorders

Published: February 03, 2023

Paraneoplastic Neurologic Disorders.

Journal: Current neurology and neuroscience reports

Published: January 17, 2023

Premorbid cognitive functioning influences differences between self-reported cognitive difficulties and cognitive assessment in multiple sclerosis.

Journal: Journal of neuropsychology

Published: October 17, 2022

What would improve MS clinic services for cognition? - A stakeholder panel and survey exploration.

Journal: Multiple sclerosis and related disorders

Published: April 26, 2022

Cognitive reserve in multiple sclerosis: The role of depression and fatigue.

Cognitive reserve in multiple sclerosis: The role of depression and fatigue.

Characterisation of Platelet Releasate Proteome in Relapsing-Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics.

Characterisation of Platelet Releasate Proteome in Relapsing-Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics.

Corrigendum to: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10 G>T at the intron 9/exon 10 of the MAPT gene.

Corrigendum to: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10 G>T at the intron 9/exon 10 of the MAPT gene.

A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies.

A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies.

Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry.

Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry.

Autoimmune central nervous system disorders: Antibody testing and its clinical utility.

Autoimmune central nervous system disorders: Antibody testing and its clinical utility.

Systematic review of cognitive reserve in multiple sclerosis: Accounting for physical disability, fatigue, depression, and anxiety.

Systematic review of cognitive reserve in multiple sclerosis: Accounting for physical disability, fatigue, depression, and anxiety.

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.

Neuropsychology intervention for managing invisible symptoms of MS (NIMIS-MS) group: A pilot effectiveness and acceptability study.

Neuropsychology intervention for managing invisible symptoms of MS (NIMIS-MS) group: A pilot effectiveness and acceptability study.

Paraneoplastic Neurologic Disorders.

Paraneoplastic Neurologic Disorders.

Premorbid cognitive functioning influences differences between self-reported cognitive difficulties and cognitive assessment in multiple sclerosis.

Premorbid cognitive functioning influences differences between self-reported cognitive difficulties and cognitive assessment in multiple sclerosis.

What would improve MS clinic services for cognition? - A stakeholder panel and survey exploration.

What would improve MS clinic services for cognition? - A stakeholder panel and survey exploration.

Corrigendum to: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10 G>T at the intron 9/exon 10 of the MAPT gene.

Corrigendum to: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10 G>T at the intron 9/exon 10 of the MAPT gene.